Answers are grounded in this paper and cite their sources.
Relapsing polychondritis (RP) is a rare immune-mediated inflammatory disease classically presenting with auricular and nasal chondritis. Cases with isolated persistent chest pain as the sole initial complaint are extremely rare and easily misdiagnosed. This atypical case provides evidence for the diagnostic value of technetium-99 m (Tc-99m) bone scintigraphy in early detection of multisite active cartilage inflammation, filling the gap in clinical recognition of RP with atypical thoracic onset. A 61-year-old male presented with 40 days of refractory anterior sternocostal chest pain unresponsive to antibiotics and nonsteroidal anti-inflammatory drugs (NSAIDs). Laboratory tests showed markedly elevated inflammatory markers and ferritin, while routine autoimmune, cardiac and infectious screening was negative. Tc-99m bone scintigraphy demonstrated diffuse abnormal radiotracer uptake in cervical and costal cartilages; airway CT revealed tracheobronchial wall thickening and calcification; audiometry confirmed bilateral high-frequency sensorineural hearing loss. No typical auricular or nasal cartilage lesions were observed. The patient was diagnosed with RP involving cervical, costal, tracheobronchial cartilages, combined with bilateral sensorineural hearing loss. Combined immunosuppressive therapy was initiated: glucocorticoids + methotrexate + monthly tocilizumab (480 mg, 8 mg/kg). Three-month follow-up bone scintigraphy showed reduced cartilage radiotracer uptake; chest pain was substantially relieved, CRP and ESR returned to normal reference ranges, while serum ferritin decreased markedly but remained slightly above the upper limit of normal. RP should be included in the differential diagnosis of unexplained refractory chest pain without ear/nose lesions. Low-cost, widely available Tc-99m bone scintigraphy enables early identification of active cartilage inflammation, shortens diagnostic delay, and facilitates timely immunosuppressive intervention to improve patient prognosis. Not applicable.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: